The global Cell Therapy Manufacturing Market is estimated to be valued at US$ 12.99 Mn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cell therapy manufacturing involves development and expansion of cells that can repair or replace damaged tissues and cells. The growing prevalence of chronic diseases such as cancer has increased the demand for cell therapies.
Market key trends:
AI assisted learning has emerged as a major trend in cell therapy manufacturing. AI and machine learning algorithms are used for cell selection, characterization, expansion and monitoring. They help optimize manufacturing processes, improve quality control and productivity. AI also helps design personalized medicine approaches in cell therapy. It analyses huge amounts of patient data to determine best treatment options.
Segment Analysis
The Global Cell Therapy Manufacturing Market Size is segmented on the basis of type, end user, and geography. By type, the market is segmented into stem cells, immune cells, and other types of cells. The stem cells segment dominates the market as stem cells have wide applications in research, development of new therapies, and treatment of various diseases. Stem cells can be differentiated into different cell types of the body and they are constantly renewing themselves through cell division. Due to their self-renewal capacity and ability to differentiate, stem cells have great potential for the development of cell-based therapies and regenerative medicines to treat diseases.
Key Takeaways
The global cell therapy manufacturing market size is expected to reach US$ 12.99 Mn in 2023 and is anticipated to grow at a CAGR of 15% during the forecast period of 2023 to 2030. The high growth is attributed to rising incidences of chronic diseases and increasing investments in cell-based research.
Regional analysis - North America dominates the global cell therapy manufacturing market. The presence of advanced healthcare infrastructure, prominent market players, and rising adoption of cell therapy are key factors responsible for its dominance. Asia Pacific is anticipated to witness the fastest growth over the coming years owing to growing public awareness about cell therapy, increasing government support, and rising healthcare expenditure in the region.
Key players - Key players operating in the cell therapy manufacturing market are WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., HEALIOS K.K., Lonza, Merck KGaA., Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD, Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., and Astellas Pharma Inc. Of these, WuXi AppTec, Inc. dominates the market owing to its global presence and strong manufacturing capabilities.
For More Insights, Read- https://www.newsstatix.com/cell-therapy-manufacturing-market-size-share-analysis-2023-2030/
After losing all the impression of their achievements, great companies often fade away.
When the whole world was shifting towardsdigital photography in late 80s, Kodak refused to join the bandwagon, and continued with their existing products even after inventing the digital camera technology.
However, after 2010, Nokia's market value declined by about 90 percent and in 2011 Nokia was acquired by Microsoft.
why Nokia, which was considered as the undisputed king of mobile devices was thrown out of the market?The main reason is the introduction of iPhone in 2007.
At the time of iPhone's launch, half of all the devices sold in the planet were Nokia's.
Nokia's management thought they will continue to rule the market with dated Symbian OS and average phones.They never thought Apple would come-up with a superior hardware and software and the executives were afraid to acknowledge the fact even after knowing that it would take several years to develop a better OS that could compete with iOS.
